Toward optimizing pomalidomide therapy in MM patients

Research output: Journal article (peer-reviewed)Journal article

1 Citation (Scopus)

Abstract

In this issue of Blood, Sehgal et al report on the clinical and pharmacodynamics analysis of pomalidomide dosing strategies in multiple myeloma (MM) and their impact on immune activation and cereblon targets. The particular novelty of this study lies in the direct correlation of immune effects triggered by pomalidomide with clinical responses in MM patients. Results of this study will stimulate many additional studies.

Original languageEnglish
Pages (from-to)3968-3969
Number of pages2
JournalBlood
Volume125
Issue number26
DOIs
Publication statusPublished - 25 Jun 2015
Externally publishedYes

Keywords

  • Angiogenesis Inhibitors/therapeutic use
  • Female
  • Humans
  • Male
  • Multiple Myeloma/drug therapy
  • Thalidomide/analogs & derivatives

Fingerprint

Dive into the research topics of 'Toward optimizing pomalidomide therapy in MM patients'. Together they form a unique fingerprint.

Cite this